Matchpoint Therapeutics

0 followers


Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, mach... Read more

Employees

11-50

Links

Org chart

Andre Turenne
President and CEO

Andre Turenne

Collapse
Christopher Hren
Vice President, Corporate Development & Operations
Jared Cumming
Chief Scientific Officer
Mark Jedrychowski, PhD
Senior Director and Head of Proteomics
Paul Renhowe
Vice President, Head of Drug Discovery